Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nurix Therapeutics

11.49
-0.1300-1.12%
Post-market: 11.490.00000.00%17:10 EDT
Volume:1.48M
Turnover:17.04M
Market Cap:875.95M
PE:-4.10
High:11.88
Open:11.73
Low:11.22
Close:11.62
Loading ...
Dec 12, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Oct 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 12, 2023

Major Issues Report

Form 8-K - Current report
Sep 07, 2023

Major Issues Report

Form 8-K - Current report
Jul 13, 2023

Major Issues Report

Form 8-K - Current report
Jul 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2023

Major Issues Report

8-K - Current report
Apr 13, 2023

Major Issues Report

8-K - Current report
Apr 13, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 10, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 24, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 09, 2023

Major Issues Report

8-K - Current report